Work

P01.23 Veliparib (V) in Combination with Carboplatin/Paclitaxel (C/P)-Based Chemoradiotherapy (CRT) in Patients With Stage III NSCLC

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.347

Authors: D. Kozono, T. Stinchcombe, J. Salama, J. Bogart, W. Petty, M. Guarino, L. Bazhenova, J. Larner, J. Weiss, T. Dipetrillo, S. Feigenberg, X. Chen, Z. Sun, S. Nuthalapati, L. Rosenwinkel, E. Johnson, B. Bach, Y. Luo, E. Vokes

Institutions: Dana-Farber Cancer Institute, Duke University, SUNY Upstate Medical University, Wake Forest University, Christiana Care Health System, University of California San Diego, University of Virginia, University of North Carolina at Chapel Hill, Rhode Island Hospital, University of Maryland, Baltimore, AbbVie (United States), University of Chicago

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3136785701

Cites:

Cited by:

Related to: 10